Schwetz B.New Treatment for Chronic Myelogenous Leukemia.The Journal of The American Medical Association. 2001Schwetz BA. New Treatment for Chronic Myelogenous Leukemia. JAMA. 2001; 286:35.Schwetz BA.New treatment for chronic myelogenous leukemia[J].2001,28....
The role of interferon in the treatment of chronic myelogenous leukemia: results and prospects. Leukemia and Lymphoma 1992: 6: 305-3 15.MORRA, E., LAZZARINO, M., ALIMENA, G, LIBERATI, A.M., GRIGNANI, F., MANDELLI, F., and BERNASCONI, C. (1992). The role of interferon in the ...
To the Editor: In 1979, we reported the results of treating 19 patients who had acute myelogenous leukemia in first remission with intensive chemotherapy, radiation therapy, and transplantation of allogeneic marrow from HLA-identical siblings between March 1976 and March 1978.1 These patients had been...
Polyriboinosinic: polyribocytidylic acid as an adjunct to remission maintenance therapy in acute myelogenous leukemia WD Terry, D Windhorst (Eds.), Immunotherapy of Cancer: Present Status of Trials in Man, Raven, New York (1978), p. 423 Google Scholar 4 RR Ellison, JF Holland, M Weil, C...
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and un... The use of low-dose, irradiation-based preparative regimens have allowed the extension of allografting to older and medically infirm patients. ...
Treatment of chronic myelogenous leukemia - Current status and future prospects [2]Thesuccessofsmallmoleculesuchasimatinib,nilotinib,anddasatinibforthetreatmentofchronicmyelogenousleukemia,sunitinibandsorafenibforthetreatmentofrenalcellcarcinoma,... GM E.,S T. 被引量: 0发表: 2012年 加载更多来源...
Panobinostat for the treatment of acute myelogenous leukemia. Expert opinion on investigational drugs. 2016; 25: 1117-31.Morabito, F.; Voso, M.T.; Hohaus, S.; Gentile, M.; Vigna, E.; Recchia, A.G.; Iovino, L.; Benedetti, E.; Lo-Coco, F.; Galimberti, S. Panobinostat for the ...
Chronic myelogenous leukemia (CML) involves the clonal expansion of hemopoietic progenitor cells associated with a characteristic translocation between chromosomes 9 and 22, resulting in the generation of an aberrant bcr-abl protein with enhanced tyrosine kinase activity. Although the precise molecular event...
You may hear other names for acute myeloid leukemia, including: Acute myelocytic leukemia Acute myelogenous leukemia Acute granulocytic leukemia Acute nonlymphocytic leukemia AML is rare; only about 1% of all cancers are AML. It usually affects people who are older than 45 years, and it's more ...
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Current Therapeutic Research 72 , 150-163 /Frederick RAppelbaum. (2001) Perspectives on the future of chronic myeloid leukemia treatment. Seminars in ... JM Goldman,R Szydlo,MM Horowitz,...